TRLS

Trellus Health PLC

Health Care First-pass screen £0.56m

320/1000 Overall fit

AI beneficiary 35% 30

Operating leverage 25% 40

Valuation 25% 30

Downside protection 15% 28

First-pass take

Early-stage health tech with minimal revenue ($114k), mounting losses ($7.2m EBITDA loss, growing YoY), and material going-concern uncertainty through October 2025. Platform lacks explicit AI/ML exposure. No demonstrated operating leverage despite software model. Customer concentration on large pharma/health-plan deals creates revenue volatility.

Flags

going-concernmicro-caploss-makingearly-stagecustomer-concentrationno-valuation-datacash-runway-4m